Gene Delivery Technologies Market Size, Share, Trends, Growth Outlook

Gene Delivery Technologies Market is estimated to increase at a growth rate of 14.5% CAGR over the forecast period from 2024 to 2030.

The Gene Delivery Technologies Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Mode (Biological, Chemical, Physical), By Application (Gene Therapy, Cell Therapy, Vaccines, Research), By Method (Ex vivo, In vivo, In vitro).

 

An Introduction to Gene Delivery Technologies Market in 2024

The gene delivery technologies market in 2024 addresses the demand for non-viral and viral vectors, gene therapy vectors, and nucleic acid delivery systems used in gene transfer, gene editing, and gene modulation applications for biomedical research, gene therapy, and genetic engineering, enabling the targeted delivery of therapeutic genes, RNA molecules, and genome editing tools into target cells, tissues, and organs for gene-based therapies, genetic modifications, and cellular reprogramming. Gene delivery technologies encompass a variety of viral vectors (adenovirus, lentivirus, adeno-associated virus) and non-viral vectors (liposomes, nanoparticles, polymers) as well as physical methods (electroporation, sonoporation, microinjection) and biological approaches (viral vectors, cell-penetrating peptides) for facilitating nucleic acid delivery, cellular uptake, and transgene expression in vitro and in vivo, offering versatility, safety, and scalability for gene therapy applications. Market dynamics are driven by factors such as the increasing investment in gene therapy research and development, the growing pipeline of gene-based therapeutics and gene editing technologies, and advancements in gene delivery vectors, genome engineering tools, and targeted gene delivery strategies for enhanced therapeutic efficacy and precision medicine applications. Collaboration between gene therapy companies, biotechnology firms, and academic researchers drives innovation and market growth in gene delivery technologies, supporting more efficient gene transfer, targeted gene editing, and personalized gene therapies for genetic disorders, rare diseases, and cancer immunotherapy.

 

Gene Delivery Technologies Market Trend: Advancements in Viral Vector Technology

A significant trend in the Gene Delivery Technologies market is the continuous advancements in viral vector technology. Viral vectors, such as adenovirus, lentivirus, and adeno-associated virus (AAV), are widely utilized for delivering therapeutic genes into target cells for gene therapy applications. Recent innovations in viral vector design, engineering, and manufacturing have led to enhanced safety profiles, improved transduction efficiency, and reduced immunogenicity, driving the adoption of viral vectors in gene delivery for treating various genetic disorders, cancers, and infectious diseases.

Gene Delivery Technologies Market Driver: Rising Investment in Gene Therapy Research and Development

A key driver in the Gene Delivery Technologies market is the increasing investment in gene therapy research and development. With the growing understanding of the genetic basis of diseases and advancements in molecular biology and genome editing technologies, there is a surge in the development of gene-based therapeutics for addressing unmet medical needs. Pharmaceutical companies, biotechnology firms, and academic research institutions are heavily investing in gene delivery technologies to accelerate the translation of gene therapy concepts from preclinical studies to clinical trials, fostering innovation and driving market growth.

Gene Delivery Technologies Market Opportunity: Targeted Gene Delivery for Precision Medicine

An opportunity for market expansion in the Gene Delivery Technologies market lies in the development of targeted gene delivery systems for precision medicine applications. Targeted gene delivery approaches aim to deliver therapeutic genes specifically to diseased cells or tissues while minimizing off-target effects on healthy tissues, thereby improving treatment efficacy and safety. By leveraging advanced targeting ligands, such as antibodies, peptides, and aptamers, gene delivery technologies can be tailored to specific cell types, organs, or disease microenvironments, paving the way for personalized gene therapy approaches and precision medicine interventions. Companies investing in the development of targeted gene delivery platforms stand to capitalize on the growing demand for precision therapeutics and personalized healthcare solutions.

 

Gene Delivery Technologies Market Segmentation

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

 

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

 

By Method

Ex vivo

In vivo

In vitro

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Gene Delivery Technologies Market Companies

Bio-Rad Laboratories Inc

Catalent Inc

Hoffmann-La Roche AG

Horizon Discovery Group Co.

OriGene Technologies Inc

Oxford Biomedica

Promega Corp

QIAGEN

SignaGen Laboratories

Sirion-Biotech GmbH

System Biosciences llc

Takara Bio Inc

Thermo Fisher Scientific Inc

Vectalys

*- List Not Exhaustive

 

Reasons to Buy the Gene Delivery Technologies Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Gene Delivery Technologies Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Gene Delivery Technologies Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Gene Delivery Technologies Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Gene Delivery Technologies Market Size Outlook, $ Million, 2021 to 2030

3.2 Gene Delivery Technologies Market Outlook by Type, $ Million, 2021 to 2030

3.3 Gene Delivery Technologies Market Outlook by Product, $ Million, 2021 to 2030

3.4 Gene Delivery Technologies Market Outlook by Application, $ Million, 2021 to 2030

3.5 Gene Delivery Technologies Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Gene Delivery Technologies Market Industry

4.2 Key Market Trends in Gene Delivery Technologies Market Industry

4.3 Potential Opportunities in Gene Delivery Technologies Market Industry

4.4 Key Challenges in Gene Delivery Technologies Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Gene Delivery Technologies Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Gene Delivery Technologies Market Outlook By Segments

7.1 Gene Delivery Technologies Market Outlook by Segments

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

By Method

Ex vivo

In vivo

In vitro

 

8 North America Gene Delivery Technologies Market Analysis And Outlook To 2030

8.1 Introduction to North America Gene Delivery Technologies Markets in 2024

8.2 North America Gene Delivery Technologies Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Gene Delivery Technologies Market size Outlook by Segments, 2021-2030

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

By Method

Ex vivo

In vivo

In vitro

 

9 Europe Gene Delivery Technologies Market Analysis And Outlook To 2030

9.1 Introduction to Europe Gene Delivery Technologies Markets in 2024

9.2 Europe Gene Delivery Technologies Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Gene Delivery Technologies Market Size Outlook By Segments, 2021-2030

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

By Method

Ex vivo

In vivo

In vitro

 

10 Asia Pacific Gene Delivery Technologies Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Gene Delivery Technologies Markets in 2024

10.2 Asia Pacific Gene Delivery Technologies Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Gene Delivery Technologies Market size Outlook by Segments, 2021-2030

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

By Method

Ex vivo

In vivo

In vitro

 

11 South America Gene Delivery Technologies Market Analysis And Outlook To 2030

11.1 Introduction to South America Gene Delivery Technologies Markets in 2024

11.2 South America Gene Delivery Technologies Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Gene Delivery Technologies Market size Outlook by Segments, 2021-2030

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

By Method

Ex vivo

In vivo

In vitro

 

12 Middle East And Africa Gene Delivery Technologies Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Gene Delivery Technologies Markets in 2024

12.2 Middle East and Africa Gene Delivery Technologies Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Gene Delivery Technologies Market size Outlook by Segments, 2021-2030

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

By Method

Ex vivo

In vivo

In vitro

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Bio-Rad Laboratories Inc

Catalent Inc

Hoffmann-La Roche AG

Horizon Discovery Group Co.

OriGene Technologies Inc

Oxford Biomedica

Promega Corp

QIAGEN

SignaGen Laboratories

Sirion-Biotech GmbH

System Biosciences llc

Takara Bio Inc

Thermo Fisher Scientific Inc

Vectalys

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Gene Delivery Technologies Market Segmentation

By Mode

Biological

-Adenovirus

-Retrovirus

-AAV

-Lentivirus

-Others

-Non-viral

Chemical

Physical

 

By Application

Gene Therapy

Cell Therapy

Vaccines

Research

 

By Method

Ex vivo

In vivo

In vitro

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)